Help From the Hill Could Add to Pharma ETFs’ Gains
November 16, 2013 at 07:00 AM EST
Congress is working on reform legislation in the pharmaceutical industry to stomp out copycat drug makers, lifting large pharmaceutical stocks and related exchange traded funds. The SPDR S&P Pharmaceuticals ETF (NYSEArca: XPH) was the best performing non-leveraged ETF over the past week,...